This document provides state by state information on implementation of intensive care coordination using a wraparound approach for children and youth with complex mental and substance use disorders.

This Clinical Guide provides comprehensive, national guidance for optimal management of pregnant and parenting women with opioid use disorder and their infants. The Clinical Guide helps healthcare professionals and patients determine the most clinically appropriate action for a particular situation and informs individualized treatment decisions.

This report presents 2016 national estimates of use of alcohol, tobacco products, illicit drugs (such as, marijuana, cocaine, heroin, hallucinogens, and inhalants, as well as the misuse of opioids, prescription pain relievers, tranquilizers, stimulants, and sedatives), substance use disorders, and substance use treatment among people 12 years of age and older. It Includes national estimates of any mental illness, serious mental illness, major depressive episode, use of mental health services and suicidal ideation among adults ages 18 or older and national estimates of major depressive episode, use of mental health services among adolescents aged 12 to 17. Trend information on these topics are also presented.

This resource provides information for clinicians who may encounter patients living with cognitive deficits related to chronic substance use disorder.

This guide offers best practices for treating women living with substance use disorders in co-ed treatment and recovery settings. It highlights the importance of gender differences, cultural sensitivity, and developing healthy relationships.

This advisory defines attention deficit hyperactivity disorder in adults, and explains interactions with substance use disorders.

This NSDUH report discusses trends in the prevalence of mental illness, substance use disorders, or both among adolescents and adults in the United States.

This manual provides guidelines for the operation of opioid treatment programs. It covers patient assessment, treatment planning, and recovery care. The manual also offers guidance for medication-assisted treatment for methadone and buprenorphine, and overdose and relapse prevention.

This guide introduces professional care providers to borderline personality disorder (BPD). It covers signs and symptoms of BPD, with or without co-occurring substance use disorder. The guide also discusses the importance of monitoring clients for self-harm and suicide, and referrals to treatment.

This report discusses national estimates on the prevalence of mental illness and the use of mental health services among people ages 12 years and older. It also presents data about co-occurring mental illness and substance use disorders.